{"id":"W2076653959","doi":"10.1186/1756-0500-6-82","title":"Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010","year":2013,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Medical prescription; Adverse effect; Pharmacy; Emergency medicine; Demography; Database; Internal medicine; Family medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006154164,0.0003846846,0.0004574402,0.002617545,0.001201698,0.001104132,0.001165366,0.0004318311,0.001830255],"category_scores_gemma":[0.003136905,0.0002632393,0.0009598402,0.006148451,0.000382881,0.0003636665,0.0006473927,0.0009465101,0.000217693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03630913,"about_ca_system_score_gemma":0.03375157,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9920104,"about_ca_topic_score_gemma":0.9928415,"domain_scores_codex":[0.9986982,0.00005665631,0.0001213701,0.0001622727,0.0006713161,0.0002901731],"domain_scores_gemma":[0.9957836,0.0001358898,0.001420985,0.00006482986,0.002045525,0.0005491301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002610981,0.00003762744,0.9847723,0.0001470199,0.0001868569,0.0001201215,0.0002250935,0.0003877212,0.0001373919,0.0001165546,0.004749896,0.008858315],"study_design_scores_gemma":[0.00001267686,0.0000220698,0.9966484,0.00005235694,0.00006627676,0.00008583062,0.0002121219,0.0003547021,0.00007619619,0.00001585493,0.002440312,0.00001320278],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9240084,0.006167944,0.0002228911,0.001713468,0.00007106582,0.0001218503,0.06026687,0.00009021423,0.007337366],"genre_scores_gemma":[0.97995,0.002842584,0.0003994174,0.0003900513,0.00003212566,0.00004181522,0.01477253,0.00001358295,0.00155793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03630913,"threshold_uncertainty_score":0.2634424,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06498338321101246,"score_gpt":0.3274777053683683,"score_spread":0.2624943221573559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}